Founder And President
Co-Founding Partner and COO
Chief Financial Officer
Chief People Officer
Partner, Launch Excellence Practice Lead
Partner, Patient Services Practice Lead
Partner, Market Access Practice Lead
General Manager, SixSense Strategy Group, Medical Affairs Practice Lead
Principal, Medical Communications
Principal, Evidence and Value
Principal, Science and Strategy
Principal, Evidence and Value
Principal, Market Access
Principal, Market Access
Principal
Principal
Principal, Scientific Communications
Principal, Science and Strategy
Senior Director, Market Access
Senior Vice President, Commercialization
Vice President, Commercialization
Director, Market Access
Senior Vice President, Commercialization
Director, Patient Services
Vice President, Business Development
Executive Vice President, Business Development
Senior Vice President, Commercialization
Jay Jackson, PharmD, MPH, BCMAS is a partner at Herspiegel and an experienced market access professional within the biopharmaceutical, medical device, and digital therapeutics industry. For more than 20 years, Jay has partnered with US and global clients of varying sizes and product portfolios to provide value-driven solutions that demonstrate brand value and maximize patient access to therapies. He has experience across multiple therapeutic areas, including oncology, cardiovascular, respiratory, autoimmune, infectious disease, central nervous system disorders, and rare diseases. He received his Doctor of Pharmacy degree from the Mercer University Southern School of Pharmacy and a Master of Public Health in Epidemiology from the University of South Florida College of Public Health. He also has postdoctoral training that includes the completion of an Outcomes Research Fellowship and a Board Certification in Medical Affairs.
Explore Herspiegel's expert strategies for successful rare disease launches, from tech innovation to market responsiveness. Learn more now.
Unlock personalized drug launch success with Herspiegel's archetype strategies. Dive into tailored planning for impactful market entry.
Discover the vast impact of rare diseases affecting 30M Americans & the struggle for diagnosis. Dive deeper into their stories.
A global pharmaceutical company worked with us to plan their European Union (EU) access strategy for a novel oncolytic drug based on a new formulation. Read the case study.
Our client, a mid-sized biopharmaceutical company, aimed to introduce a new asset into the highly competitive Parkinson's disease category. Read the case study.
Discover how to tailor product launches effectively with our Archetype Playbook. Master your market strategy now.
Navigate market access complexities for launch success with key trends and insights. Elevate your strategy – Read our report now.
Explore 5 key strategies the Build Back Better Act employs to cut drug costs. Essential insights for pharma strategy. Click to learn more.
Careers page Analyst profile
Careers page Manager profile
Careers page, Principal profile